About Xinkeshu and puerarin treatment of unstable angina.docVIP

 PAGE \* MERGEFORMAT 6 About Xinkeshu and puerarin treatment of unstable angina [Keywords:] Xinkeshu tablets, puerarin, unstable angina October 2004 -2005 in October, and the author on the basis of conventional western medicine, the application Xinkeshu tablets and puerarin treatment of unstable angina pectoris (UAP) 30 patients treated with conventional western medicine for 30 cases were , satisfactory results are reported below. 1 Materials and Methods 1.1 General Information The Department of Cardiology, 60 patients were hospitalized patients, WHO 1979 diagnostic criteria established by UAP. The patients were randomly divided into 2 groups: treatment group of 30 patients, 16 males and 14 females, aged from 45 to 76 years (mean 60.3 + -9.2) years; the shortest duration of 2 d, up to l0 years, the average (6.2 + -2.5) years, of which l0 onset exertional angina patients, 16 cases of worsening exertional angina, myocardial infarction heart colic in 4 cases. control group of 30 patients, 15 males and 15 females, aged 46 to 75 years, mean (59.6 +-l0.2) years, the shortest duration of 3 d, up to l0 years, the average (6.l + -2.8) years, in which onset exertional angina in 11 cases, 15 cases of worsening exertional angina, myocardial infarction, angina pectoris in 4 cases. 2 groups were no significant differences between data, comparable. 1.2 Treatment 2 groups were utilized, are bed rest, oxygen, conventional oral isosorbide dinitrate l0 mg tid, aspirin 100 mg qd, and Coenzyme Q10 Capsules 20 mg tid, while to l0 mg of nitroglycerin was added in 250 mL normal saline intravenously , 1 / d. On this basis, the treatment group to Xinkeshu tablets (Shandong Weifang in the pharmaceutical production) 3 tablets, 3 times / d, orally, puerarin (Guangdong Yantang Biochemistry Pharmaceutical Co) 200 mg addition of 250 mL normal saline intravenously 1 / d, 7 d. conjunction 1.3 Observation items ① angina attack frequency and duration, ② before admissio